Although these inhibitors may have application in malignant glioma, they may have an even broader application for cancer, as p75NTR has also been implicated in other cancers, including melanoma, specifically the more aggressive melanomas that metastasize to the brain [96–98]. Here, NGFR is linked to cancer.